Medicine and Dentistry
Ovarian Cancer
100%
Krukenberg Tumor
58%
Chemotherapy
48%
Malignant Neoplasm
48%
Neoplasm
36%
Shared Decision Making
32%
Breast Cancer
31%
Veliparib
20%
Progression Free Survival
19%
Overall Survival
19%
Patient-Reported Outcome
18%
Recurrent Disease
18%
Patient Participation
16%
CA-125
16%
Consultation
15%
Decision Making
14%
Base Excision Repair
14%
Disease
14%
Recurrent Ovarian Cancer
13%
Ovarian Tumor
13%
Hazard Ratio
12%
Homologous Recombination
11%
Biological Marker
11%
Oncology
10%
Epidermal Growth Factor Receptor
10%
Paclitaxel
10%
Diagnosis
10%
Immunohistochemistry
9%
Cancer Therapy
9%
Bevacizumab
9%
Doxorubicin
9%
Human Epididymis Protein 4
9%
Panitumumab
9%
Clinician
9%
Protein Expression
8%
Platelet Derived Growth Factor
8%
Poly ADP Ribose Polymerase
7%
Gynecological Oncology
7%
Oncologist
7%
Female Genital Tract Cancer
7%
Vasculotropin
7%
Phase II Trials
7%
Drug Therapy
7%
Platinum-Resistant Ovarian Cancer
7%
Cancer Cell
7%
Multivariate Analysis
7%
Health Care
7%
Enzymes
7%
Cohort Analysis
6%
BRCA1
6%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
86%
Neoplasm
29%
Ovary Carcinoma
26%
Chemotherapy
25%
Progression Free Survival
23%
Malignant Neoplasm
23%
Overall Survival
21%
Biological Marker
18%
Recurrent Disease
17%
Breast Cancer
15%
Bevacizumab
13%
Paclitaxel
12%
Carboplatin
10%
Vasculotropin
10%
Ovary Tumor
10%
Veliparib
9%
Disease
9%
Combination Therapy
8%
Circulating Tumor DNA
7%
Female Genital Tract Cancer
6%
Platelet Derived Growth Factor
6%
Pandemic
6%
Gamma Interferon
6%
Disseminated Cancer
6%
Epidermal Growth Factor Receptor
6%
Human Epididymis Protein 4
6%
Randomized Controlled Trial
6%
Receptor
5%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
5%
Nursing and Health Professions
Shared Decision-Making
66%
Ovary Cancer
24%
Breast Cancer
24%
Malignant Neoplasm
20%
Patient-Reported Outcome
19%
Health Care Personnel
16%
Patient Participation
14%
Disease
11%
Confidence Interval
9%
Systematic Review
9%
Recurrent Disease
9%
Health Service
9%
Advanced Cancer
8%
Patient Preference
6%
Emergency Ward
6%
Glioma
6%
Lumbar Disk Hernia
6%
Pandemic
6%
Physician
5%
Drug Therapy
5%
Palliative Therapy
5%